WO2003040330A8 - Therapeutic polypeptides, nucleic acids encoding same, and methods of use - Google Patents

Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Info

Publication number
WO2003040330A8
WO2003040330A8 PCT/US2002/035536 US0235536W WO03040330A8 WO 2003040330 A8 WO2003040330 A8 WO 2003040330A8 US 0235536 W US0235536 W US 0235536W WO 03040330 A8 WO03040330 A8 WO 03040330A8
Authority
WO
WIPO (PCT)
Prior art keywords
methods
nucleic acids
acids encoding
encoding same
therapeutic polypeptides
Prior art date
Application number
PCT/US2002/035536
Other languages
French (fr)
Other versions
WO2003040330A2 (en
Inventor
John P Ii Alsobrook
Enrique Alvarez
David W Anderson
Melanie Baron
Ferenc L Boldog
Catherine E Burgess
Stacie J Casman
Andrei Chapoval
Mohanraj Dhanabal
Shlomit R Edinger
Original Assignee
Curagen Corp
John P Ii Alsobrook
Enrique Alvarez
David W Anderson
Melanie Baron
Ferenc L Boldog
Catherine E Burgess
Stacie J Casman
Andrei Chapoval
Mohanraj Dhanabal
Shlomit R Edinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, John P Ii Alsobrook, Enrique Alvarez, David W Anderson, Melanie Baron, Ferenc L Boldog, Catherine E Burgess, Stacie J Casman, Andrei Chapoval, Mohanraj Dhanabal, Shlomit R Edinger filed Critical Curagen Corp
Priority to EP02793885A priority Critical patent/EP1539985A4/en
Priority to JP2003542577A priority patent/JP2005520496A/en
Priority to CA002460653A priority patent/CA2460653A1/en
Priority claimed from US10/287,971 external-priority patent/US20040067882A1/en
Publication of WO2003040330A2 publication Critical patent/WO2003040330A2/en
Publication of WO2003040330A8 publication Critical patent/WO2003040330A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PCT/US2002/035536 2001-11-05 2002-11-05 Therapeutic polypeptides, nucleic acids encoding same, and methods of use WO2003040330A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02793885A EP1539985A4 (en) 2001-11-05 2002-11-05 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2003542577A JP2005520496A (en) 2001-11-05 2002-11-05 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use
CA002460653A CA2460653A1 (en) 2001-11-05 2002-11-05 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Applications Claiming Priority (38)

Application Number Priority Date Filing Date Title
US33862601P 2001-11-05 2001-11-05
US60/338,626 2001-11-05
US33660001P 2001-12-05 2001-12-05
US60/336,600 2001-12-05
US33828501P 2001-12-07 2001-12-07
US60/338,285 2001-12-07
US34134601P 2001-12-12 2001-12-12
US60/341,346 2001-12-12
US34147701P 2001-12-17 2001-12-17
US34154001P 2001-12-17 2001-12-17
US60/341,540 2001-12-17
US60/341,477 2001-12-17
US34259201P 2001-12-20 2001-12-20
US60/342,592 2001-12-20
US34429701P 2001-12-27 2001-12-27
US60/344,297 2001-12-27
US34490301P 2001-12-31 2001-12-31
US60/344,903 2001-12-31
US37328802P 2002-04-17 2002-04-17
US60/373,288 2002-04-17
US38098102P 2002-05-15 2002-05-15
US60/380,981 2002-05-15
US38149502P 2002-05-17 2002-05-17
US60/381,495 2002-05-17
US38353402P 2002-05-28 2002-05-28
US38374402P 2002-05-28 2002-05-28
US60/383,744 2002-05-28
US60/383,534 2002-05-28
US38402402P 2002-05-29 2002-05-29
US38382902P 2002-05-29 2002-05-29
US60/384,024 2002-05-29
US60/383,829 2002-05-29
US40178802P 2002-08-07 2002-08-07
US60/401,788 2002-08-07
US40635302P 2002-08-26 2002-08-26
US60/406,353 2002-08-26
US10/287,971 2002-10-31
US10/287,971 US20040067882A1 (en) 2001-10-22 2002-11-05 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Publications (2)

Publication Number Publication Date
WO2003040330A2 WO2003040330A2 (en) 2003-05-15
WO2003040330A8 true WO2003040330A8 (en) 2005-04-21

Family

ID=32512865

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/035536 WO2003040330A2 (en) 2001-11-05 2002-11-05 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Country Status (3)

Country Link
EP (1) EP1539985A4 (en)
CA (1) CA2460653A1 (en)
WO (1) WO2003040330A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20050053988A1 (en) * 2003-08-08 2005-03-10 The Gov. Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Gene expressed in breast cancer and methods of use
US7939634B2 (en) 2004-01-27 2011-05-10 Compugen Ltd. Polynucleotides encoding polypeptides and methods using same
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
DK1781698T3 (en) 2004-07-20 2016-10-03 Genentech Inc COMPOSITIONS AND METHODS FOR THE USE OF Angiopoietin-like-4-PROTEIN
PL1771474T3 (en) 2004-07-20 2010-07-30 Genentech Inc Inhibitors of angiopoietin-like 4 protein, combinations, and their use
WO2006043271A1 (en) * 2004-10-22 2006-04-27 Compugen Ltd. Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
US10842849B2 (en) * 2011-02-28 2020-11-24 The Schepens Eye Research Institute, Inc. Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033996A2 (en) * 1996-03-11 1997-09-18 Bayer Corporation Human bikunin

Also Published As

Publication number Publication date
EP1539985A2 (en) 2005-06-15
CA2460653A1 (en) 2003-05-15
EP1539985A4 (en) 2006-06-28
WO2003040330A2 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
WO2003023008A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1576169A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1487864A4 (en) Therapeutic polypeptides nucleic acids encoding same, and methods of use
AU2002356534A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2001296333A1 (en) Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
EP1446419A4 (en) Therapeutic polypeptides, nucleic acids encoding the same, and methods of use
AU2003217956A1 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
EP1432726A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1401858A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003040330A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1532238A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003083039A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002334781A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
EP1399537A4 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
EP1549671A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002309646A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002365216A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003023002A9 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003304034A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003060149A9 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003270424A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002360485A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002322405A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1504026A4 (en) Therapeutic polypeptides, nucleic acids encodings same, and methods of use
AU2002303232A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2460653

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002359353

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003542577

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002793885

Country of ref document: EP

D17 Declaration under article 17(2)a
WWP Wipo information: published in national office

Ref document number: 2002793885

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002793885

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)